Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof

Details for Australian Patent Application No. 2008309004 (hide)

Owner GlaxoSmithKline LLC

Inventors Banker, Pierette; Dickerson, Scott Howard; Thomson, Stephen Andrew; Tavares, Francis X.; Garrido, Dulce Maria; Sparks, Steven Meagher

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-A-2008309004

PCT Pub. Number WO2009/045831

Priority 60/975,865 28.09.07 US

Filing date 25 September 2008

Wipo publication date 9 April 2009

International Classifications

C07D 213/64 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

A61K 31/4418 (2006.01) - having a carbocyclic ring directly attached to the heterocyclic ring, e.g. cyproheptadine

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

Event Publications

6 May 2010 PCT application entered the National Phase

  PCT publication WO2009/045831 Priority application(s): WO2009/045831

1 March 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008309010-Methods and formulations for converting intravenous and injectable drugs into oral dosage forms

2008309003-Glycogen phosphorylase inhibitor compound and pharmaceutical composition thereof